Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.
Lacro RV, Dietz HC, Wruck LM, Bradley TJ, Colan SD, Devereux RB, Klein GL, Li JS, Minich LL, Paridon SM, Pearson GD, Printz BF, Pyeritz RE, Radojewski E, Roman MJ, Saul JP, Stylianou MP, Mahony L; Pediatric Heart Network Investigators.
Lacro RV, et al. Among authors: colan sd.
Am Heart J. 2007 Oct;154(4):624-31. doi: 10.1016/j.ahj.2007.06.024.
Am Heart J. 2007.
PMID: 17892982
Free PMC article.
Clinical Trial.